FDA Approves GLP-1 Drugs for Fatty Liver Disease With 63% Success Rate
New clinical trials show GLP-1 medications like Ozempic can reverse fatty liver disease in up to 62% of patients within 72 weeks.
2142 articles in this topic
New clinical trials show GLP-1 medications like Ozempic can reverse fatty liver disease in up to 62% of patients within 72 weeks.
Revolutionary AI tool can forecast disease onset years in advance, potentially transforming preventive healthcare and longevity strategies.
New analysis claims dangerous lead levels in protein powders, but the safety thresholds used may be unnecessarily strict.
Dr. Stanfield reveals why longevity investments crash and burn, plus four medication classes showing real promise for healthspan extension.
New research reveals how muscle stem cells fine-tune their activation through alternative RNA splicing mechanisms.
UK Biobank study reveals vigorous activity has 4-9x greater health benefits than moderate exercise, challenging standard recommendations.
Scientists used human brain cells on microchips to decode how genetic mutations lead to ataxia, migraines, and epilepsy.
New research reveals how cholesterol-lowering medications dramatically reduce dementia risk when used long-term.
Researchers developed 50 stem cell lines from HIV patients to understand genetic factors that determine disease progression.
New research suggests falling testosterone levels may be due to changed testing methods, not actual biological decline.
International society creates comprehensive roadmap to translate pluripotent stem cell research into approved medicines worldwide.
A large study suggests melatonin increases heart failure risk, but critical methodology problems may invalidate the alarming findings.